About Insulet Corporation

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, USA, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. Omnipod® provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, many patients across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives.

Starting July 2018, Insulet began direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training, and customer support activities. This allowed Insulet to be closer to the diabetes community and to identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.